ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Initial treatment of trichomoniasis in immunocompetent adults

Initial treatment of trichomoniasis in immunocompetent adults
Treatment of trichomoniasis is indicated for all symptomatic and asymptomatic persons with confirmed infection. Treatment reduces the prevalence of T. vaginalis in the population, relieves symptoms (when present), and reduces the risk of sequelae (including acquisition or transmission of HIV). Systemic oral therapy is preferred over topical therapy (eg, vaginal treatment) because it is significantly more effective. 5-nitroimidazole drugs (eg, metronidazole, tinidazole, and secnidazole) are the preferred agents.

NAAT: nucleic acid amplification test.

* If testing has not been done, preferred tests include NAAT, nucleic acid probe, or rapid antigen tests. Trichomonads on wet mount, cervical cytology, or culture also warrant treatment.

¶ Metronidazole is preferred in pregnancy and lactation. Safety data for tinidazole and secnidazole are insufficient.

Δ Metronidazole oral suspension 250 mg (2.5 mL) orally three times daily for seven days.

◊ Treatment option per World Health Organization but to be avoided in first trimester if possible.

§ While metronidazole is secreted in breastmilk, the dose received through breastmilk is lower than the dosage used to treat infections in infants.

¥ The concentration of metronidazole in breast milk is lower with the 400 mg dose given three times a day compared with 500 mg given twice a day. However, 400 mg tablets are not universally available and more frequent dosing may be more challenging.

‡ For individuals who wish to avoid any metronidazole exposure to their infants, we advise pumping and discarding breast milk for 12 hours after the 2 gm single oral dose. Some clinicians advise deferring lactation for 12 to 24 hours after single-dose metronidazole treatment because the relative infant dose of metronidazole is higher with the 2 gm single dose compared with multi-day dosing.

† The World Health Organization offers multi-dose tinidazole (500 mg orally twice daily for seven days) as an alternative treatment for initial infection. We reserve this treatment for patients with confirmed persistent infection despite adequate initial treatment.
Information from:
  1. Jack Sobel, MD.
  2. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines. MMWR Recomm Rep 2021; 70:1.
  3. Guidelines for the management of symptomatic sexually transmitted infections [Internet]. Geneva: World Health Organization, 2021.
Graphic 132757 Version 7.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟